Patents Assigned to The University of Kentucky Research Foundation
  • Patent number: 8946152
    Abstract: A method of treating Parkinson's disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to one or both putamen of a human in need of treatment thereof via convection-enhanced infusion using at least one implantable pump and at least one catheter. In one aspect of the present invention the GDNF is infused directly into one or both putamen through one or more indwelling intraparenchymal mutitiport brain catheters connected to one or moreimplantable pumps wherein the flow rate is pulsed.
    Type: Grant
    Filed: September 22, 2005
    Date of Patent: February 3, 2015
    Assignees: Amgen Inc., University of Kentucky Research Foundation
    Inventors: Steven S. Gill, Don M. Gash, Greg Allen Gerhardt
  • Patent number: 8940261
    Abstract: A contaminant-tolerant hybrid scrubbing solvent is provided for post-combustion CO2 capture and removal, the scrubbing solvent including an amine and a low fraction of ammonia. A stripping carrier having a low latent energy is included for solvent regeneration. In one embodiment, the amine is MEA and the stripping chemical having low latent energy is pentane or an isomer thereof. Processes and apparatus for CO2 removal from post-combustion gases and for solvent regeneration are described.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: January 27, 2015
    Assignee: The University of Kentucky Research Foundation
    Inventors: Kunlei Liu, James Kyle Neathery, Joseph Eugene Remias
  • Patent number: 8927971
    Abstract: Disclosed are semiconducting compounds having one or more phthalimide units and/or one or more head-to-head (H-H) substituted biheteroaryl units. Such compounds can be monomeric, oligomeric, or polymeric, and can exhibit desirable electronic properties and possess processing advantages including solution?processability and/or good stability at ambient conditions.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: January 6, 2015
    Assignee: University of Kentucky Research Foundation
    Inventor: Mark D. Watson
  • Patent number: 8906300
    Abstract: A blood oxygenator includes an integral pneumatic pump disposed substantially within a housing thereof, an inlet blood flow redirector, and an outflow blood collector. An atrium provided at an inlet of the oxygenator promotes even delivery of blood to the oxygenator. In use, the oxygenator provides an even dispersion of blood therethrough, establishing even perfusion and reducing areas of stagnant blood flow.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: December 9, 2014
    Assignee: The University of Kentucky Research Foundation
    Inventors: Dongfang Wang, Joseph B. Zwischenberger
  • Publication number: 20140356613
    Abstract: A carbon nanotube studded carbon fiber tow and matrix prepreg includes a body comprising a tow of surface fibers and interior bulk fibers. The surface fibers are studded with carbon nanotubes and the carbon fibers are infiltrated with a matrix material.
    Type: Application
    Filed: May 31, 2013
    Publication date: December 4, 2014
    Applicants: Materials Sciences Corporation, The University of Kentucky Research Foundation
    Inventors: Matthew Collins Weisenberger, John Davis Craddock, Richard Foedinger
  • Publication number: 20140342357
    Abstract: The presently-disclosed subject matter includes methods of identifying an Alu RNA inhibitor, and methods and compositions for inhibiting Alu RNA. Methods and compositions can be used for the treatment of geographic atrophy and other conditions of interest.
    Type: Application
    Filed: July 3, 2014
    Publication date: November 20, 2014
    Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventor: Jayakrishna Ambati
  • Patent number: 8884027
    Abstract: Melampomagnolide B is disclosed as a new antileukemic sesquiterpene. A biotin-conjugated derivative of melampomagnolide B was prepared to elucidate its mechanism of action. Prodrugs of Melampomagnolide B are disclosed.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: November 11, 2014
    Assignees: University of Rochester, University of Kentucky Research Foundation
    Inventors: Peter A. Crooks, Craig T. Jordan, Shanshan Pei, Shama Nasim
  • Publication number: 20140329453
    Abstract: A ventilation system for an underground mine includes a blowing curtain, a passive regulator in a shape of an airfoil and an airflow ventilation source. The passive regulator is positioned in the air path adjacent a discharge end of the blowing curtain.
    Type: Application
    Filed: May 1, 2014
    Publication date: November 6, 2014
    Applicant: University of Kentucky Research Foundation
    Inventors: Andrzej M. Wala, Todor P. Petrov
  • Publication number: 20140329285
    Abstract: A method for on-farm processing a biomass feedstock into a useful industrial chemicals includes the steps of (a) delignifying the biomass feedstock to produce a delignified biomass, (b) subjecting the delignified biomass to cellulase production, (c) subjecting the delignified biomass with attached cellulase to simultaneous cellulolytic and solventogenic reactions to produce useful industrial chemicals (d) collecting and separating the useful industrial chemical from the fermentation broth and (e) collecting the fermentation residues.
    Type: Application
    Filed: October 25, 2013
    Publication date: November 6, 2014
    Applicant: The University of Kentucky Research Foundation
    Inventors: Sue E. Nokes, Bert C. Lynn, Stephen Rankin, Barbara Knutson, Michael D. Montross, Michael Flythe
  • Publication number: 20140311386
    Abstract: A hybrid cement clinker incorporates specific ranges of clinker phases and falls within specific modulus values as set forth and described in this document.
    Type: Application
    Filed: February 14, 2014
    Publication date: October 23, 2014
    Applicant: University of Kentucky Research Foundation
    Inventors: Thomas Robl, Tristana Duvallet, Robert Rathbone, Yongmin Zhou
  • Patent number: 8865150
    Abstract: The present invention relates to pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules of interest, namely active pharmaceuticals. The gels comprise a pharmaceutically acceptable pH-sensitive polymer that responds to a lowering of pH by precipitating into films when in contact with the skin or mucosal surface. The films also comprise an adhesive polymer that allows the film to remain in contact with the tissue for an extended period of time. The wax-film composites comprise a bi-layer film having both the said pH-sensitive mucoadhesive layer to promote strong adherence to the skin and mucosal surfaces as well as a specially bonded wax layer intended to extend the adherence of the film to tissues for a prolonged period of time.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: October 21, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Russell Mumper, Michael Jay
  • Patent number: 8852551
    Abstract: Primitive or progenitor hematologic cancer cells have been implicated in the early stages and development of leukemia and malignant lymphoproliferative disorders, including acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML) and chronic lymphoid leukemia (CLL). Interleukin-3 receptor alpha chain (IL-3R? or CD123) is strongly expressed on progenitor hematologic cancer cells, but is virtually undetectable on normal bone marrow cells. The present invention provides methods of impairing progenitor hematologic cancer (e.g., leukemia and lymphomic) cells by selectively targeting cells expressing CD123. These methods are useful in the detection and treatment of leukemias and malignant lymphoproliferative disorders. Also provided are compounds useful for selectively binding to CD123 and impairing progenitor hematologic cancer cells. These compounds may include cytotoxic moieties such as, for example, radioisotopes or chemotherapeutics.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: October 7, 2014
    Assignee: University of Kentucky Research Foundation
    Inventor: Craig Jordan
  • Publication number: 20140295311
    Abstract: An electrolyte system for a flow battery has an anolyte including [Fe(CN)6]3? and [Fe(CN)6]4? and a catholyte including Fe2+ and Fe3+.
    Type: Application
    Filed: May 23, 2012
    Publication date: October 2, 2014
    Applicant: University of Kentucky Research Foundation
    Inventors: Stephen M. Lipka, Christopher R. Swartz
  • Publication number: 20140294704
    Abstract: A solvent for removal of an acid gas from a fluid stream includes a promoter amine with a pKa of between 6.5 and 10.5 and a tertiary amine with a pKa of between 8.5 and 10.5.
    Type: Application
    Filed: March 29, 2013
    Publication date: October 2, 2014
    Applicant: The University of Kentucky Research Foundation
    Inventors: Joseph E. Remias, Cameron A. Lippert, Kunlei Liu
  • Publication number: 20140296061
    Abstract: A novel transition metal trimer compound/catalyst is disclosed. A method of increasing the overall mass transfer rate of acid gas scrubbing solvents utilizing that catalyst is also provided.
    Type: Application
    Filed: March 29, 2013
    Publication date: October 2, 2014
    Applicant: The University of Kentucky Research Foundation
    Inventor: The University of Kentucky Research Foundation
  • Publication number: 20140294705
    Abstract: A method of increasing the overall mass transfer rate of acid gas scrubbing solids is disclosed. Various catalyst compounds for that purpose are also disclosed.
    Type: Application
    Filed: March 29, 2013
    Publication date: October 2, 2014
    Applicant: The University of Kentucky Research Foundation
    Inventors: Joseph E. Remias, Cameron A. Lippert, Kunlei Liu
  • Patent number: 8846937
    Abstract: Provided are monoquaternary ammonium compounds which are modulators of nicotinic acetylcholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse, and or gastrointestinal tract disorders.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: September 30, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Peter Crooks, Linda P. Dwoskin, Guangrong Zheng, Sangeetha Sumithran, Zhenfa Zheng
  • Patent number: 8846386
    Abstract: Disclosed herein are nucleic acid molecules comprising a nucleotide sequence of sVEGF-2, proteins encoded by those sequences and antibodies that bind to the protein. Also disclosed are methods for inhibiting or enhancing expression or activity of sVEGFR-2 and methods for inhibiting graft rejection, particularly cornea graph rejection. Also described are methods for inhibiting lymphangiogenesis and lymphatic endothelial cell proliferation by administering an effective amount of sVEGFR-2 and methods for treating lymphedema by inhibiting the activity of sVEGFR-2.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: September 30, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Jayakrishna Ambati, Rumulo J. C. Albuquerque
  • Patent number: 8846887
    Abstract: Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (?)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (?)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: September 30, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Chang-Guo Zhan, Fang Zheng, Wenchao Yang
  • Patent number: 8841014
    Abstract: An electrode for a lithium ion battery includes a liquid metal having a melting point that is below the operating temperature of the battery, which transforms from a liquid to a solid during lithiation, and wherein the liquid metal transforms from a solid to a liquid during delithiation.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: September 23, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Rutooj D. Deshpande, Juchuan Li, Yang-Tse Cheng